HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Skin care R&D company has entered into a definitive agreement to sell the exclusive North American marketing and distribution rights for its patented Antimicrobial Hand Sanitizer to Dermal Defense, firm reports Feb. 23. Additionally, Skinvisible has extended the deadline of a previous offer to Dermal Defense for rights to the hand sanitizer in territories outside the U.S., Canada and Mexico to March 30, company says. If Dermal Defense accepts the offer, the firm will be required to pay $1 mil. and 5% royalty on all product sales globally, Skinvisible notes...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts